Wakamoto PharmaceuticalWAKAMOTO PHARMACEUTICAL CO.,LTD.4512東証スタンダード医薬品FY ending Mar 2026, non-consolidated, J-GAAP

What does Wakamoto Pharmaceutical do with its cash?

How cash from operations was spent on investment, dividends, buybacks and more.

※ Operating cash flow is negative

Operating cash flow
-¥486.9M
Capex
¥615.8M
of revenue 6.2%
Free cash flow
-¥1.1B
Returned to shareholders
¥104.1M
of net income: 46%
Dividend per share
¥3.5
Payout ratio (reported)
53.5%

Cash flow ratios

Cash conversion, investment and shareholder payments calculated from disclosed figures.

Net income¥227.2M
Operating cash flow-¥486.9M
Cash conversion (operating CF ÷ operating income)
-190.5%
Cash vs. profit gap
-¥714.1M(純利益の -314.3%)
Shareholder returns
of net income 45.8%
Shareholder payments — dividends
of net income 45.8%
CapEx intensity (capex ÷ revenue)
6.2%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

Five-year trend

Operating cash flow-¥486.9M
FY ending Mar 2022: ¥339.2M¥339.2MFY ending Mar 2023: ¥631.9M¥631.9MFY ending Mar 2024: -¥107.3M-¥107.3MFY ending Mar 2025: -¥592.5M-¥592.5MFY ending Mar 2026: -¥486.9M-¥486.9MFY22FY23FY24FY25FY26
Free cash flow-¥1.1B
FY ending Mar 2022: ¥36.4M¥36.4MFY ending Mar 2023: ¥469M¥469MFY ending Mar 2024: -¥663M-¥663MFY ending Mar 2025: -¥1.07B-¥1.07BFY ending Mar 2026: -¥1.1B-¥1.1BFY22FY23FY24FY25FY26
Net income¥227.2M
FY ending Mar 2022: ¥238.5M¥238.5MFY ending Mar 2023: ¥138.3M¥138.3MFY ending Mar 2024: ¥109M¥109MFY ending Mar 2025: ¥64.4M¥64.4MFY ending Mar 2026: ¥227.2M¥227.2MFY22FY23FY24FY25FY26

How to read this

  • Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
  • Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
  • Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第131期(2025/04/01-2026/03/31)

    ID S100YDBU2026-06-18Open
  • EDINET (FSA Japan)

    有価証券報告書-第130期(2024/04/01-2025/03/31)

    ID S100W0QM2025-06-20Open
  • EDINET (FSA Japan)

    有価証券報告書-第129期(2023/04/01-2024/03/31)

    ID S100TTRJ2024-06-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第128期(2022/04/01-2023/03/31)

    ID S100R6G72023-06-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第127期(令和3年4月1日-令和4年3月31日)

    ID S100OCE22022-06-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第126期(令和2年4月1日-令和3年3月31日)

    ID S100LMJG2021-06-25Open

Extracted from XBRL: 47 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.